Literature DB >> 7665409

Skeletal muscle mitochondrial function studied by kinetic analysis of postexercise phosphocreatine resynthesis.

C H Thompson1, G J Kemp, A L Sanderson, G K Radda.   

Abstract

To investigate mitochondrial regulation and its response to a defect in oxidative metabolism, we used 31P-magnetic resonance spectroscopy to study phosphocreatine (PCr) recovery in rat leg muscle after sciatic nerve stimulation at 1-4 Hz. We studied normal animals and animals with defective skeletal muscle mitochondrial function after experimental cardiac infarction. To analyze these data, we used three current theoretical approaches to the control of mitochondrial ATP synthesis, based on its hyperbolic relationship to cytosolic ADP concentration and on its linear relationships to PCr concentration and the free energy of ATP hydrolysis. The mitochondrial ADP concentration for one-half maximum rate of ATP synthesis appeared at least twice as high as the 30 microM expected from in vitro studies. According to all three approaches, the apparent maximum rate of ATP synthesis was independent of stimulation frequency and end-exercise pH and PCr and ADP concentrations and was reduced by approximately 50% after experimental cardiac infarction. Analysis of PCr recovery kinetics is a robust and practical way to study mitochondrial regulation and to quantify effective mitochondrial defects in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665409     DOI: 10.1152/jappl.1995.78.6.2131

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  25 in total

1.  Parameter estimation in modeling phosphocreatine recovery in human skeletal muscle.

Authors:  Laurent M Arsac; Eric Thiaudière; Philippe Diolez; Léo Gerville-Réache
Journal:  Eur J Appl Physiol       Date:  2003-11-19       Impact factor: 3.078

Review 2.  In vivo MR investigation of skeletal muscle function in small animals.

Authors:  B Giannesini; P J Cozzone; D Bendahan
Journal:  MAGMA       Date:  2004-12-10       Impact factor: 2.310

3.  Mitochondrial coupling in humans: assessment of the P/O2 ratio at the onset of calf exercise.

Authors:  V Cettolo; M Cautero; E Tam; M P Francescato
Journal:  Eur J Appl Physiol       Date:  2007-01-06       Impact factor: 3.078

4.  Theoretical modelling of some spatial and temporal aspects of the mitochondrion/creatine kinase/myofibril system in muscle.

Authors:  G J Kemp; D N Manners; J F Clark; M E Bastin; G K Radda
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

5.  Influence of cytosolic pH on in vivo assessment of human muscle mitochondrial respiration by phosphorus magnetic resonance spectroscopy.

Authors:  R Lodi; G J Kemp; S Iotti; G K Radda; B Barbiroli
Journal:  MAGMA       Date:  1997-06       Impact factor: 2.310

6.  Impact of creatine on muscle performance and phosphagen stores after immobilization.

Authors:  Jeremy C Fransen; Micah Zuhl; Chad M Kerksick; Nathan Cole; Steve Altobelli; Dean O Kuethe; Suzanne Schneider
Journal:  Eur J Appl Physiol       Date:  2015-04-18       Impact factor: 3.078

Review 7.  Multiple sprint work : physiological responses, mechanisms of fatigue and the influence of aerobic fitness.

Authors:  Mark Glaister
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

8.  Impact of length during repetitive contractions on fatigue in rat skeletal muscle.

Authors:  Meredith B MacNaughton; Brian R MacIntosh
Journal:  Pflugers Arch       Date:  2007-05-01       Impact factor: 3.657

9.  Short-term training alters the control of mitochondrial respiration rate before maximal oxidative ATP synthesis.

Authors:  G Layec; L J Haseler; J Hoff; C R Hart; X Liu; Y Le Fur; E-K Jeong; R S Richardson
Journal:  Acta Physiol (Oxf)       Date:  2013-05-02       Impact factor: 6.311

10.  Recovery dynamics of skeletal muscle oxygen uptake during the exercise off-transient.

Authors:  Brad J Behnke; Leonardo F Ferreira; P J McDonough; Timothy I Musch; David C Poole
Journal:  Respir Physiol Neurobiol       Date:  2009-07-18       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.